Literature DB >> 19233184

Gut homing receptors on CD8 T cells are retinoic acid dependent and not maintained by liver dendritic or stellate cells.

Bertus Eksteen1, J Rodrigo Mora, Emma L Haughton, Neil C Henderson, Laura Lee-Turner, Eduardo J Villablanca, Stuart M Curbishley, Alex I Aspinall, Ulrich H von Andrian, David H Adams.   

Abstract

BACKGROUND & AIMS: Lymphocytes primed by intestinal dendritic cells (DC) express the gut-homing receptors CCR9 and alpha4beta7, which recognize CCL25 and mucosal addressin cell-adhesion molecule-1 in the intestine promoting the development of regional immunity. In mice, imprinting of CCR9 and alpha4beta7 is dependent on retinoic acid during T-cell activation. Tissue specificity is lost in primary sclerosing cholangitis (PSC), an extraintestinal manifestation of inflammatory bowel disease, when ectopic expression of mucosal addressin cell-adhesion molecule-1 and CCL25 in the liver promotes recruitment of CCR9+alpha4beta7+ T cells to the liver. We investigated the processes that control enterohepatic T-cell migration and whether the ability to imprint CCR9 and alpha4beta7 is restricted to intestinal DCs or can under some circumstances be acquired by hepatic DCs in diseases such as PSC.
METHODS: Human and murine DCs from gut, liver, or portal lymph nodes and hepatic stellate cells were used to activate CD8 T cells. Imprinting of CCR9 and alpha4beta7 and functional migration responses were determined. Crossover activation protocols assessed plasticity of gut homing.
RESULTS: Activation by gut DCs imprinted high levels of functional CCR9 and alpha4beta7 on naïve CD8 T cells, whereas hepatic DCs and stellate cells proved inferior. Imprinting was RA dependent and demonstrated plasticity.
CONCLUSIONS: Imprinting and plasticity of gut-homing human CD8 T cells requires primary activation or reactivation by gut DCs and is retinoic acid dependent. The inability of liver DCs to imprint gut tropism implies that alpha4beta7+CCR9+ T cell that infiltrate the liver in PSC are primed in the gut.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19233184      PMCID: PMC3201985          DOI: 10.1053/j.gastro.2009.02.046

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  33 in total

1.  Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin.

Authors:  Andrew J Stagg; Michael A Kamm; Stella C Knight
Journal:  Eur J Immunol       Date:  2002-05       Impact factor: 5.532

Review 2.  Intestinal attraction: CCL25 functions in effector lymphocyte recruitment to the small intestine.

Authors:  Daniel J Campbell; Eugene C Butcher
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

3.  Characterization of CCR9 expression and CCL25/thymus-expressed chemokine responsiveness during T cell development: CD3(high)CD69+ thymocytes and gammadeltaTCR+ thymocytes preferentially respond to CCL25.

Authors:  Shoji Uehara; Kaimei Song; Joshua M Farber; Paul E Love
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

4.  Rapid resolution of chronic colitis in the cotton-top tamarin with an antibody to a gut-homing integrin alpha 4 beta 7.

Authors:  P E Hesterberg; D Winsor-Hines; M J Briskin; D Soler-Ferran; C Merrill; C R Mackay; W Newman; D J Ringler
Journal:  Gastroenterology       Date:  1996-11       Impact factor: 22.682

5.  CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease.

Authors:  K A Papadakis; J Prehn; S T Moreno; L Cheng; E A Kouroumalis; R Deem; T Breaverman; P D Ponath; D P Andrew; P H Green; M R Hodge; S W Binder; S R Targan
Journal:  Gastroenterology       Date:  2001-08       Impact factor: 22.682

6.  The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system.

Authors:  K A Papadakis; J Prehn; V Nelson; L Cheng; S W Binder; P D Ponath; D P Andrew; S R Targan
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

7.  Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor gammadelta(+) gut intraepithelial lymphocytes.

Authors:  M A Wurbel; M Malissen; D Guy-Grand; E Meffre; M C Nussenzweig; M Richelme; A Carrier; B Malissen
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

8.  Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease.

Authors:  Allister J Grant; Sarah Goddard; Jalal Ahmed-Choudhury; Gary Reynolds; David G Jackson; Michael Briskin; Lijun Wu; Stefan G Hübscher; David H Adams
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

9.  Demonstration of functional role of TECK/CCL25 in T lymphocyte-endothelium interaction in inflamed and uninflamed intestinal mucosa.

Authors:  Naoki Hosoe; Soichiro Miura; Chikako Watanabe; Yoshikazu Tsuzuki; Ryota Hokari; Tokushige Oyama; Yoichi Fujiyama; Hiroshi Nagata; Hiromasa Ishii
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-10-30       Impact factor: 4.052

10.  Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells.

Authors:  J Rodrigo Mora; Maria Rosa Bono; N Manjunath; Wolfgang Weninger; Lois L Cavanagh; Mario Rosemblatt; Ulrich H Von Andrian
Journal:  Nature       Date:  2003-07-03       Impact factor: 49.962

View more
  48 in total

Review 1.  Vitamin A and immune regulation: role of retinoic acid in gut-associated dendritic cell education, immune protection and tolerance.

Authors:  Barbara Cassani; Eduardo J Villablanca; Jaime De Calisto; Sen Wang; J Rodrigo Mora
Journal:  Mol Aspects Med       Date:  2011-11-22

Review 2.  The role of chemokines in the recruitment of lymphocytes to the liver.

Authors:  Ye H Oo; Shishir Shetty; David H Adams
Journal:  Dig Dis       Date:  2010-05-07       Impact factor: 2.404

3.  Differential regulation of CD103 (αE integrin) expression in human dendritic cells by retinoic acid and Toll-like receptor ligands.

Authors:  Mandi M Roe; Steve Swain; T Andrew Sebrell; Marisa A Sewell; Madison M Collins; Brian A Perrino; Phillip D Smith; Lesley E Smythies; Diane Bimczok
Journal:  J Leukoc Biol       Date:  2017-01-13       Impact factor: 4.962

Review 4.  Management of primary sclerosing cholangitis: conventions and controversies.

Authors:  Natasha Chandok; Gideon M Hirschfield
Journal:  Can J Gastroenterol       Date:  2012-05       Impact factor: 3.522

Review 5.  Characterization of animal models for primary sclerosing cholangitis (PSC).

Authors:  Peter Fickert; Marion J Pollheimer; Ulrich Beuers; Carolin Lackner; Gideon Hirschfield; Chantal Housset; Verena Keitel; Christoph Schramm; Hanns-Ulrich Marschall; Tom H Karlsen; Espen Melum; Arthur Kaser; Bertus Eksteen; Mario Strazzabosco; Michael Manns; Michael Trauner
Journal:  J Hepatol       Date:  2014-02-19       Impact factor: 25.083

6.  The "gut microbiota" hypothesis in primary sclerosing cholangitis.

Authors:  Valerio Pontecorvi; Marco Carbone; Pietro Invernizzi
Journal:  Ann Transl Med       Date:  2016-12

7.  Epidermis instructs skin homing receptor expression in human T cells.

Authors:  Michelle L McCully; Kristin Ladell; Svetlana Hakobyan; Robert E Mansel; David A Price; Bernhard Moser
Journal:  Blood       Date:  2012-10-04       Impact factor: 22.113

Review 8.  Vitamin A and retinoic acid in T cell-related immunity.

Authors:  A Catharine Ross
Journal:  Am J Clin Nutr       Date:  2012-10-10       Impact factor: 7.045

9.  Adjuvanted influenza vaccine administered intradermally elicits robust long-term immune responses that confer protection from lethal challenge.

Authors:  Maria del P Martin; Shaguna Seth; Dimitrios G Koutsonanos; Joshy Jacob; Richard W Compans; Ioanna Skountzou
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

Review 10.  Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies.

Authors:  James H Tabibian; Steven P O'Hara; Keith D Lindor
Journal:  Scand J Gastroenterol       Date:  2014-07-03       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.